107 related articles for article (PubMed ID: 17189169)
1. Modified keratin sponge: binding of bone morphogenetic protein-2 and osteoblast differentiation.
Tachibana A; Nishikawa Y; Nishino M; Kaneko S; Tanabe T; Yamauchi K
J Biosci Bioeng; 2006 Nov; 102(5):425-9. PubMed ID: 17189169
[TBL] [Abstract][Full Text] [Related]
2. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate.
Takahashi Y; Yamamoto M; Tabata Y
Biomaterials; 2005 Aug; 26(23):4856-65. PubMed ID: 15763265
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.
Jeon O; Song SJ; Kang SW; Putnam AJ; Kim BS
Biomaterials; 2007 Jun; 28(17):2763-71. PubMed ID: 17350678
[TBL] [Abstract][Full Text] [Related]
4. Rapid fabrication of keratin-hydroxyapatite hybrid sponges toward osteoblast cultivation and differentiation.
Tachibana A; Kaneko S; Tanabe T; Yamauchi K
Biomaterials; 2005 Jan; 26(3):297-302. PubMed ID: 15262471
[TBL] [Abstract][Full Text] [Related]
5. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
[TBL] [Abstract][Full Text] [Related]
6. Functionalization of multilayered DNA-coatings with bone morphogenetic protein 2.
van den Beucken JJ; Walboomers XF; Boerman OC; Vos MR; Sommerdijk NA; Hayakawa T; Fukushima T; Okahata Y; Nolte RJ; Jansen JA
J Control Release; 2006 Jun; 113(1):63-72. PubMed ID: 16687187
[TBL] [Abstract][Full Text] [Related]
7. Osteogenic differentiation of rabbit mesenchymal stem cells in thermo-reversible hydrogel constructs containing hydroxyapatite and bone morphogenic protein-2 (BMP-2).
Na K; Kim SW; Sun BK; Woo DG; Yang HN; Chung HM; Park KH
Biomaterials; 2007 Jun; 28(16):2631-7. PubMed ID: 17331575
[TBL] [Abstract][Full Text] [Related]
8. Enhanced osteogenic promotion around dental implants with synthetic binding motif mimicking bone morphogenetic protein (BMP)-2.
Seol YJ; Park YJ; Lee SC; Kim KH; Lee JY; Kim TI; Lee YM; Ku Y; Rhyu IC; Han SB; Chung CP
J Biomed Mater Res A; 2006 Jun; 77(3):599-607. PubMed ID: 16506173
[TBL] [Abstract][Full Text] [Related]
9. The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2.
Lin H; Zhao Y; Sun W; Chen B; Zhang J; Zhao W; Xiao Z; Dai J
Biomaterials; 2008 Mar; 29(9):1189-97. PubMed ID: 18083224
[TBL] [Abstract][Full Text] [Related]
10. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells.
Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F
J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361
[TBL] [Abstract][Full Text] [Related]
11. BMP stimulation of alkaline phosphatase activity in pluripotent mouse C2C12 cells is inhibited by dermatopontin, one of the most abundant low molecular weight proteins in demineralized bone matrix.
Behnam K; Murray SS; Brochmann EJ
Connect Tissue Res; 2006; 47(5):271-7. PubMed ID: 17118749
[TBL] [Abstract][Full Text] [Related]
12. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
13. Immobilization of bone morphogenetic protein-2 on a nanofibrous chitosan membrane for enhanced guided bone regeneration.
Park YJ; Kim KH; Lee JY; Ku Y; Lee SJ; Min BM; Chung CP
Biotechnol Appl Biochem; 2006 Jan; 43(Pt 1):17-24. PubMed ID: 15910285
[TBL] [Abstract][Full Text] [Related]
14. Mixing conditions for cell scaffolds affect the bone formation induced by bone engineering with human bone marrow stromal cells, beta-tricalcium phosphate granules, and rhBMP-2.
Uchida M; Agata H; Sagara H; Shinohara Y; Kagami H; Asahina I
J Biomed Mater Res A; 2009 Oct; 91(1):84-91. PubMed ID: 18767063
[TBL] [Abstract][Full Text] [Related]
15. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery.
Jeon O; Song SJ; Yang HS; Bhang SH; Kang SW; Sung MA; Lee JH; Kim BS
Biochem Biophys Res Commun; 2008 May; 369(2):774-80. PubMed ID: 18313401
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of bone morphogenetic proteins (BMPs) 2, 4, 6, and 7 during induced heterotopic bone formation.
McCullough KA; Waits CA; Garimella R; Tague SE; Sipe JB; Anderson HC
J Orthop Res; 2007 Apr; 25(4):465-72. PubMed ID: 17262821
[TBL] [Abstract][Full Text] [Related]
18. Effects of growth factors on cell migration and alkaline phosphatase release.
Gonnerman KN; Brown LS; Chu TM
Biomed Sci Instrum; 2006; 42():60-5. PubMed ID: 16817586
[TBL] [Abstract][Full Text] [Related]
19. BMP-2 promotes differentiation of osteoblasts and chondroblasts in Runx2-deficient cell lines.
Liu T; Gao Y; Sakamoto K; Minamizato T; Furukawa K; Tsukazaki T; Shibata Y; Bessho K; Komori T; Yamaguchi A
J Cell Physiol; 2007 Jun; 211(3):728-35. PubMed ID: 17226753
[TBL] [Abstract][Full Text] [Related]
20. The effect of combined application of TGFbeta-1, BMP-2, and COLLOSS E on the development of bone marrow derived osteoblast-like cells in vitro.
van der Zande M; Walboomers XF; Briest A; Springer M; Alava JI; Jansen JA
J Biomed Mater Res A; 2008 Sep; 86(3):788-95. PubMed ID: 18041723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
